Development and Validation of an Age-Related Gastric Cancer-Specific Immune Index

References

• Fitzmaurice C, Abate D; Global Burden of Disease Cancer C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768. doi:10.1001/jamaoncol.2019.2996
   PubMed Web of Science ®Google Scholar
• Arias E, Xu J. United states life tables, 2018. Natl Vital Stat Rep. 2020;69(12):1–45.
   Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Takatsu Y, Hiki N, Nunobe S, et al. Clinicopathological features of gastric cancer in young patients. Gastric Cancer. 2016;19(2):472–478. doi:10.1007/s10120-015-0484-1
   PubMed Web of Science ®Google Scholar
• Nelen SD, Verhoeven RHA, Lemmens V, et al. Increasing survival gap between young and elderly gastric cancer patients. Gastric Cancer. 2017;20(6):919–928. doi:10.1007/s10120-017-0708-7
   PubMed Web of Science ®Google Scholar
• Bando H, Yamada Y, Tanabe S, et al. Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. Gastric Cancer. 2016;19(3):919–926. doi:10.1007/s10120-015-0549-1
   PubMed Web of Science ®Google Scholar
• Takahashi R, Nunobe S, Makuuchi R, et al. Survival outcomes of elderly patients with pathological stages II and III gastric cancer following curative gastrectomy. Ann Gastroenterol Surg. 2020;4(4):433–440. doi:10.1002/ags3.12339
   PubMed Web of Science ®Google Scholar
• Nunobe S, Oda I, Ishikawa T, et al. Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association. Gastric Cancer. 2020;23(2):328–338. doi:10.1007/s10120-019-01000-3
   PubMed Web of Science ®Google Scholar
• Granger A, Mott R, Emambokus N. Is aging as inevitable as death and taxes? Cell Metab. 2016;23(6):947–948. doi:10.1016/j.cmet.2016.06.003
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013;153(6):1194–1217. doi:10.1016/j.cell.2013.05.039
   PubMed Web of Science ®Google Scholar
• Lazebnik Y. What are the hallmarks of cancer? Nat Rev Cancer. 2010;10(4):232–233. doi:10.1038/nrc2827
   PubMed Web of Science ®Google Scholar
• Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685–705. doi:10.1146/annurev-physiol-030212-183653
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li T, Liang X, et al. Association of adjuvant chemotherapy with survival in patients with stage II or III gastric cancer. JAMA Surg. 2017;152(7):e171087. doi:10.1001/jamasurg.2017.1087
   PubMed Web of Science ®Google Scholar
• June CH, Blazar BR, Riley JL. Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol. 2009;9(10):704–716. doi:10.1038/nri2635
   PubMed Web of Science ®Google Scholar
• Yin X, Fang T, Wang Y, et al. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer. Cancer Med. 2021;10(3):1103–1119. doi:10.1002/cam4.3706
   PubMed Web of Science ®Google Scholar
• Zander R, Schauder D, Xin G, et al. CD4(+) T cell help is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer. Immunity. 2019;51(6):1028–42 e4. doi:10.1016/j.immuni.2019.10.009
   PubMed Web of Science ®Google Scholar
• Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20:323–370. doi:10.1146/annurev.immunol.20.100201.131730
   PubMed Web of Science ®Google Scholar
• Cowell LG. The diagnostic, prognostic, and therapeutic potential of adaptive immune receptor repertoire profiling in cancer. Cancer Res. 2020;80(4):643–654. doi:10.1158/0008-5472.CAN-19-1457
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Perreault C, Finn OJ, et al. Beneficial autoimmunity improves cancer prognosis. Nat Rev Clin Oncol. 2021;18(9):591–602. doi:10.1038/s41571-021-00508-x
   PubMed Web of Science ®Google Scholar
• Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20(2):89–106. doi:10.1038/s41568-019-0222-9
   PubMed Web of Science ®Google Scholar
• Huang Q, Cao Y, Wang S, et al. Creation of a novel inflammation-based score for operable colorectal cancer patients. J Inflamm Res. 2020;13:659–671. doi:10.2147/JIR.S271541
   PubMed Web of Science ®Google Scholar
• Li Z, Li S, Ying X, et al. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer. 2020;23(3):540–549. doi:10.1007/s10120-019-01027-6
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.21388
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2018 (edition). Gastric Cancer. 2021;24(1):1–21. doi:10.1007/s10120-020-01042-y
   PubMed Web of Science ®Google Scholar
• Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 2017;355(6331):1330–1334. doi:10.1126/science.aaf9011
   PubMed Web of Science ®Google Scholar
• Xie W, Kagiampakis I, Pan L, et al. DNA methylation patterns separate senescence from transformation potential and indicate cancer risk. Cancer Cell. 2018;33(2):309–21 e5. doi:10.1016/j.ccell.2018.01.008
   PubMed Web of Science ®Google Scholar
• Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211(2):144–156. doi:10.1002/path.2104
   PubMed Web of Science ®Google Scholar
• Maue AC, Yager EJ, Swain SL, et al. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 2009;30(7):301–305. doi:10.1016/j.it.2009.04.007
   PubMed Web of Science ®Google Scholar
• Weng NP, Hathcock KS, Hodes RJ. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity. 1998;9(2):151–157. doi:10.1016/s1074-7613(00)80597-x
   PubMed Web of Science ®Google Scholar
• Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A. 1997;94(20):10827–10832. doi:10.1073/pnas.94.20.10827
   PubMed Web of Science ®Google Scholar
• Kuss I, Hathaway B, Ferris RL, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004;10(11):3755–3762. doi:10.1158/1078-0432.CCR-04-0054
   PubMed Web of Science ®Google Scholar
• Lee WJ, Chang KJ, Lee CS, et al. Selective depression of T-lymphocyte subsets in gastric cancer patients: an implication of immunotherapy. J Surg Oncol. 1994;55(3):165–169. doi:10.1002/jso.2930550307
   PubMed Web of Science ®Google Scholar
• Cortellini A, Bersanelli M, Buti S, et al. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable. J Immunother Cancer. 2019;7(1):57. doi:10.1186/s40425-019-0527-y
   PubMed Web of Science ®Google Scholar
• Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol. 2000;20(4):250–256. doi:10.1023/a:1006611518223
   PubMed Web of Science ®Google Scholar
• Groves CJ, Carrell J, Grady R, et al. CD19-positive antibody-secreting cells provide immune memory. Blood Adv. 2018;2(22):3163–3176. doi:10.1182/bloodadvances.2017015172
   PubMed Web of Science ®Google Scholar
• Apetoh L, Smyth MJ, Drake CG, et al. Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology. 2015;4(4):e998538. doi:10.1080/2162402X.2014.998538
   PubMed Web of Science ®Google Scholar
• Han J, Zhao L, Wu J, et al. Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance. Appl Bionics Biomech. 2022;2022:1094607. doi:10.1155/2022/1094607
   PubMed Web of Science ®Google Scholar
• Khaled AR, Durum SK. The role of cytokines in lymphocyte homeostasis. Biotechniques. 2002;Suppl:40–45.
   PubMedGoogle Scholar
• Surh CD, Sprent J. Regulation of naive and memory T-cell homeostasis. Microbes Infect. 2002;4(1):51–56. doi:10.1016/s1286-4579(01)01509-x
   PubMed Web of Science ®Google Scholar
• Kugel CH, Douglass SM, Webster MR, et al. Age correlates with response to Anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations. Clin Cancer Res. 2018;24(21):5347–5356. doi:10.1158/1078-0432.CCR-18-1116
   PubMed Web of Science ®Google Scholar
• Mimura K, Teh JL, Okayama H, et al. PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci. 2018;109(1):43–53. doi:10.1111/cas.13424
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Iwasa S, Okazaki S, et al. A Phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer. Gastric Cancer. 2018;21(3):439–445. doi:10.1007/s10120-017-0753-2
   PubMed Web of Science ®Google Scholar
• Demaria M, O’Leary MN, Chang J, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017;7(2):165–176. doi:10.1158/2159-8290.CD-16-0241
   PubMed Web of Science ®Google Scholar
• Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13(1):54–61. doi:10.1038/nm1523
   PubMed Web of Science ®Google Scholar
• Emens LA. Chemotherapy and tumor immunity: an unexpected collaboration. Front Biosci. 2008;13:249–257. doi:10.2741/2675
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Apetoh L, Ghiringhelli F, et al. The anticancer immune response: indispensable for therapeutic success? J Clin Invest. 2008;118(6):1991–2001. doi:10.1172/JCI35180
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Apetoh L, Ghiringhelli F, et al. Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 2008;8(1):59–73. doi:10.1038/nri2216
   PubMed Web of Science ®Google Scholar
• Muranski P, Boni A, Wrzesinski C, et al. Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? Nat Clin Pract Oncol. 2006;3(12):668–681. doi:10.1038/ncponc0666
   PubMedGoogle Scholar
• Gattinoni L, Finkelstein SE, Klebanoff CA, et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med. 2005;202(7):907–912. doi:10.1084/jem.20050732
   PubMed Web of Science ®Google Scholar
• Wang JB, Li P, Liu XL, et al. An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer. Nat Commun. 2020;11(1):6352. doi:10.1038/s41467-020-20260-7
   PubMed Web of Science ®Google Scholar
• Shi H, Jiang Y, Cao H, et al. Nomogram based on systemic immune-inflammation index to predict overall survival in gastric cancer patients. Dis Markers. 2018;2018:1787424. doi:10.1155/2018/1787424
   PubMed Web of Science ®Google Scholar